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Abstract
Background: The Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ) is one of the most
often used questionnaires in oncology research, yet modifications to the scale are done with little evidence
of psychometric testing. This study aimed to (i) document the frequency of use of the questionnaire for ranking
(i.e., level of activity) and classification (i.e., active versus insufficiently active) purposes, (ii) summarize how the GSLTPAQ is
used in terms of item content and scoring, and (iii) evaluate the extent to which validity evidence supports the use of
the scale among cancer survivors.
Methods: A systematic review was conducted with evidence drawn from English-written articles published between
January 1st 1985 (year the GSLTPAQ was published) and December 31, 2014. A search of six databases, a scan of reference
list of included articles, and a cited reference search identified articles that reported using the GSLTPAQ among cancer
survivors.
Results: A total of 212 articles were retrieved. The GSLTPAQ was used for classifying cancer survivors into active and
insufficiently active categories in 51 % of the articles. Moreover, a modified version of the questionnaire was used in 81 %
of the research studies. Three studies reported validity evidence based on the relationship between the scores on the
GSLTPAQ (i.e., leisure score index, LSI) and accelerometer or pedometer-derived activity data. Validity evidence supporting
the use of the GSLTPAQ for assessing changes in LSI was computed from six randomized trials.
Conclusions: The use of the GSLTPAQ for classification purpose in oncology research is common. Standardization in the
use and interpretation of the GSLTPAQ in oncology research is warranted. Although limited, there is support for using the
original form of the GSLTPAQ and interpreting the LSI for ranking cancer survivors from the lowest to highest levels of
leisure-time physical activity.
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Background
Leisure-time physical activity (LTPA) is an important
subtype of physical activity (PA) for research and behav-
ior change intervention in oncology context. PA is de-
fined as ‘any bodily movement produced by skeletal
muscles that results in energy expenditure’ [1] (p.126),
whereas LTPA refers to any ‘[…] activity undertaken in
the individual’s discretionary time that increases the total
energy expenditure’ [2] (p. 12). Compared to household,
occupational, and commuting PA, LTPA is likely to be
more volitional and performed at higher intensity [1, 3,
4], which may provide greater fitness- and health- related
benefits [5, 6]. In addition, LTPA, which includes exercise
training [1, 2], is safe and rewarding for both physical
and mental health among cancer survivors [6–10].
The Godin-Shephard Leisure-Time Physical Activity
Questionnaire (GSLTPAQ; [11–13]) is a short question-
naire that is often used to assess LTPA in oncology re-
search [14, 15]. The GSLTPAQ is a 4-item self-
administered questionnaire with the first three questions
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seeking information on the number of times one engages
in mild, moderate and strenuous LTPA bouts of at least
15 min duration in a typical week. Examples of LTPA
are provided for each intensity category (for a complete
version of the questionnaire, readers are referred to
Godin [12]). Scores derived from the GSLTPAQ include
total weekly LTPA, called a Leisure Score Index (LSI), in
which number of bouts at each intensity is multiplied by
3, 5, and 9 metabolic equivalents (METs) and summed.
LSI scores can be used for ranking individuals from the
lowest to highest PA levels [16]. In addition, the score
obtained from moderate and strenuous LTPA can be
used to classify respondents into active and insufficiently
active categories according to published PA guidelines
for public health [17–19] and cancer survivors [7, 9].
The GSLTPAQ is one of the potential measures of PA
that the Division of Cancer Epidemiology & Genetics re-
search program of the National Cancer Institute recom-
mends to oncology clinicians and researchers [20].
However, the questionnaire was not reviewed or analysed
by their technical Evaluation Committee, and suggested
that it should be viewed “as starting points that can be
adapted or improved upon as appropriate” [21]. Addition-
ally, a limited amount and variety of validity evidence sup-
porting the use of the GSLTPAQ among cancer survivors
has been accumulated. This is an important drawback as
validity evidence supporting the use of this scale among ap-
parently healthy adults (e.g., [5, 11, 22–25]) may not
generalize to cancer survivors as measurement properties
may differ across populations [26, 27]. For instance, cancer
survivors’ cognitive abilities (e.g., information processing,
attention, concentration, memory) needed for effective re-
call and reporting of PA, may have been impaired by the
disease itself or its treatments [9, 28]. As a result, risk of re-
call bias may be higher in cancer survivors than in appar-
ently healthy individuals, especially for older and metastatic
cancer survivors. Accurate reporting of PA intensity may
also be more challenging for someone going through can-
cer treatment because the perception of PA intensity may
not reflect the intensity of a given PA described in the ques-
tionnaire [26, 29]. Furthermore, many researchers have
adapted the questionnaire for their own purposes without
acknowledging the implications of these adaptations on its
measurement quality. This is a meaningful shortcoming be-
cause the measurement quality of these adapted versions of
the GSLTPAQ is unknown and using poor quality LTPA
questionnaires increases the risk of misclassification and
biased results. Clinically relevant associations between
LTPA, assessed either as an exposure or an outcome, and
any other relevant variables can be mitigated or may remain
undetected when interpreting scores from poor quality
questionnaires [29–31].
In order to provide safe and effective recommenda-
tions to cancer survivors, it is critical to use
questionnaires that offer an optimal trade-off between
quality and feasibility to best capture and understand
PA among cancer survivors. Given that the quality of a
measurement tool depends on its intended use and in-
terpretation among a given population [32], the objec-
tives of this review are (i) to document the frequency
of use of the GSLTPAQ for ranking and classification
purposes, (ii) to summarize how the GSLTPAQ is used
in terms of item content and scoring methods, and (iii)
to evaluate the extent to which validity evidence sup-
ports the use of the GSLTPAQ among cancer survi-
vors. As the GSLTPAQ is inexpensive, does not require
specific skills for completion or interpretation, and can
be administered to a large number of cancer survivors
quickly and efficiently, identifying validity evidence
can help facilitate opportunities for data collection, pa-
tient monitoring and survivorship care planning, as
well as outcomes and practice-based research. This
may be particularly important for research on PA and
cancer survivorship as it could represent a unique op-
portunity to provide valuable reliable data on PA treat-
ment trials and at population level throughout the
survivorship continuum. As such, this study provides
research and practical recommendations that will fa-
cilitate the researchers’ and clinicians’ decision to use
and interpret the GSLTPAQ among cancer survivor
populations.
Methods
This systematic review and reporting of results were re-
alized in reference to the Preferred Reporting Items for
Systematic Review and Meta-Analyses (PRISMA State-
ment; [33]).
Search strategies and study selection
One reviewer (SA) identified published English-written
articles by searching six electronic databases and scan-
ning reference list of included articles. Additionally, a
cited reference search was performed using Scopus and
Web of Science in order to screen for articles that cite
the primary articles for the GSLTPAQ (i.e., [11, 22]).
The period covered by the literature review was from
January 1st 1985 (date the GSLTPAQ was published) to
December 31st 2014. Articles were restricted to those
that both assessed LTPA using the original or a modified
version of the GSLTPAQ and cited Godin & Shephard
[11] or Godin et al. [22], and (iii) were conducted among
cancer survivors. For the purpose of this study, an indi-
vidual is considered a cancer survivor from the time of
the diagnosis until the end of his or her life [34]. Full de-
tails of the information source and search strategy, study
selection, data collection, and extraction processes can
be obtained from Additional file 1.
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GSLTPAQ’s measurement purposes
Information concerning the use of the measure and pur-
pose (s) was retained [35, 36]. Specifically, the scale may
have been used for ranking and/or classification pur-
poses. PA may be assessed using the GSLTPAQ for a
number of reasons such as examining the association be-
tween PA and health outcomes, identifying correlates/
determinants of PA behavior, adjusting the association
between two variables by controlling in the analyses for
PA, reporting and describing PA prevalence within a
given population, screening participants to determine
eligibility for an intervention, evaluating the effectiveness
of an intervention, and documenting within or between
individuals changes in PA levels over time.
GSLTPAQ’s item content and scoring methods
The GSLTPAQ intended scoring is the LSI, which is
obtained using the following formula: (frequency of
mild × 3) + (frequency of moderate × 5) + (frequency of
strenuous × 9). The intended cut-point values for the
classification scoring are based on the North Ameri-
can public health PA guidelines, that are defined as
follows: individuals reporting moderate-to-strenuous
LSI ≥ 24 are classified as active whereas individuals
reporting moderate-to-strenuous LSI ≤ 23 are classi-
fied as insufficiently active (estimated energy expend-
iture < 14 Kcal/kg/week) [12]. In order to evaluate the
variations in the use of the GSLTPAQ, information con-
cerning the item content (frequency items only vs. fre-
quency and duration items), the recall period (typical or
last week vs. other recall timeframes), and scoring
methods (LSI, frequency/week, minutes/week, METs ×
hours/week, percentage meeting PA guideline, and other
measurement units) were retrieved.
Validity evidence for the use of the GSLTPAQ among
cancer survivors
Validity evidence for the use of the original version of the
GSLTPAQ among cancer survivors was retrieved. First, ef-
fect sizes [e.g., Pearson’s or Spearman’s correlation coeffi-
cient (r)] based on the relation between GSLTPAQ scores
and other device-based PA measures (e.g., accelerometer,
pedometer) reported in the reviewed articles were identified
as convergent validity evidence [16, 37]. Second, effect sizes
assessing change in the LSI were calculated. Specifically,
intervention studies that randomly assigned cancer survi-
vors to receive either a supervised and prescribed PA
training program (exercise group) or a placebo/non-PA
intervention (control group) were examined [38]. Within
this study design, it is expected that cancer survivors par-
ticipating in a supervised and prescribed PA training pro-
gram would report a greater increase in LSI than cancer
survivors who were not training. For both the exercise and
control group, effect size (i.e., Cohen’s d) reflecting the
average group mean change in LSI was calculated. Add-
itional methodological criteria were extracted to assess the
risk of bias of these studies [i.e., sequence generation
(reporting both the method and type of randomization);
blinding of study assessors to participant assignment; ad-
equate adherence rate (≥75 %) to the PA intervention;
baseline imbalance for LSI; incomplete data for LSI
(intention-to-treat analysis used, attrition rate, description
of withdrawals and dropouts, and strategies used for hand-
ling missing data are reported and appropriated)].
Data extraction
Information concerning the first and second objective
was extracted by one reviewer (SA). A second reviewer
(JL) independently extracted data from a random sample
of the included articles (Narticles = 35). An inter-rater reli-
ability value for each item was examined and discrepan-
cies were resolved by consensus between SA and JL.
Intraclass coefficient for study sample characteristics
ranged from .98 to 1.00 and kappa coefficient ranged
from .03 to .79 for study design and GSLTPAQ-related
items. After discussion between reviewers, items for which
kappa coefficient was unsatisfactory (< .41) were extracted
again from all the included articles by one of the reviewers
(SA) and corrections were made as needed. All information
concerning the third objective was independently extracted
by two reviewers (SA and JL). Both reviewers independently
evaluated the methodological quality and retrieved statis-
tical information for all relevant studies. Discrepancies were
resolved by consensus between SA and JL.
Data analysis
For the first and second objectives, information was sum-
marized using descriptive statistics (i.e., frequencies,
percentage) using SAS version 9.3 (SAS Institute, Cary,
NC, USA). For the third objective, validity estimates based
on the relation between LSI and device-based PA measures
were reported as correlation coefficients and correspond-
ing 95 % confidence interval [95 % CI]. The coefficients
were then classified based on van Poppel et al. [37] criteria.
A correlation coefficient for the GSLTPAQ-pedometer as-
sociation ≥ .30 indicates the lowest level of evidence (level
3) because pedometer assesses walking behavior and may
not capture the entire range of LTPA that cancer survivors
participate in daily. A correlation coefficient for the
GSLTPAQ-accelerometer association between .40 and .49,
and ≥ .50 indicate medium (level 2) and high (level 1) level
of evidence, respectively. Any validity estimates < .30 (for
pedometer) and < .40 (for accelerometer) were considered
as trivial and a (−) score was given (unsatisfactory evi-
dence). Based on Mendoza, Stafford, and Stauffer [39]’s
simulation study, a sample of at least 100 is recommended
for obtaining precise reliability and validity estimates.
Therefore, if the sample size was < 100, a (?) score was
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given (uncertain evidence), whereas a (+) score was given if
this sample size was ≥ 100 (satisfactory evidence).
Effect sizes for sensitivity to change validity evidence
were obtained using the following formula: (mean post-
intervention LSI – mean baseline LSI)/standard devi-
ation of baseline LSI [38]. As there are few effect sizes
reported for sensitivity to change validity evidence, they
were qualitatively appraised according to Cohen’s d cri-
teria [40]: (d ≤ .20) trivial; (d = .20) small; (d = .50)
medium; (d = .80) large. Depending of the PA dose pre-
scribed (≤2 PA sessions of at least moderate intensity/
week vs. ≥ 3 PA sessions or at least moderate intensity/
week), satisfactory validity evidence was obtained if the
validity estimate for the exercise group is medium (≤2
PA session/week) or large (≥3 PA session/week), while it
is trivial/small for the control group. Again, if the sample




The detailed process used to select studies is depicted
in Fig. 1. There were 212 published English- language
articles that reported using the GSLTPAQ to assess
LTPA among cancer survivors between 1997 (the first
evidence of the GSLTPAQ among cancer survivors)
and 2014. Fig. 2 shows an increasing trend in the use
of the questionnaire over time. As shown in Table 1,
breast cancer survivors were the most frequently
studied cancer population. In addition, 12 articles
(5.7 %) targeted youth and adolescent cancer survi-
vors (sample mean age < 18 years). A detailed sum-
mary of the characteristics of each study included in
the review is presented in the Additional file 2.
GSLTPAQ measurement purpose
As displayed in Table 2, 70.3 % and 50.9 % of the arti-
cles reported using the GSLTPAQ for ranking and classi-
fication purpose, respectively; this information was
undetectable for two studies (1.1 %) given the lack of in-
formation reported [41, 42]. Specifically, the GSLTPAQ
was most frequently used (frequency ≥ 10 %) for iden-
tifying correlates/determinants of LTPA barriers, mo-
tivation towards LTPA or future LTPA behavior
(32.1 %); examining the association between LTPA
and health-related outcomes (e.g., quality of life, fa-
tigue; 29.7 %); evaluating the effectiveness of an inter-
vention (18.4 %), comparing baseline levels of LTPA
for cancer survivors randomly allocated to one of the
experimental conditions (13.2 %), reporting and de-
scribing PA prevalence (10.9 %); or evaluating
changes in LTPA levels across the cancer experience
(i.e., before diagnosis, during treatment, and after
treatment; 10.4 %). It is worth noting that a single
study may have used the questionnaire for more than
one purpose.
GSLTPAQ item content and scoring system
Only 12.3 % of the articles reported using the GSLTPAQ
as originally intended in terms of item content (i.e., asking
three questions about the frequency of mild, moderate
and strenuous LTPA), recall period (i.e., during a typical
week or in the last week), and scoring methods (i.e., using
either LSI, frequency score or both). Further details are
provided in Table 2. In 81.1 % of the articles reviewed, a
modified version of the GSLTPAQ was used. The most
frequent modification (72.3 %) was the collection of infor-
mation on the average duration (minutes/week) for mild,
moderate and strenuous LTPA bouts. LTPA scores were
either reported as the number of minutes/week, the num-
ber of METs × hours/week, or the percentage of cancer
survivors classified as active (e.g., individuals reporting ≥
150 min of moderate-to-strenuous LTPA/week), insuffi-
ciently active (e.g., individuals reporting < 150 min of
moderate-to-strenuous LTPA/week) and sedentary
(e.g., individuals reporting 0 min of moderate-to-
strenuous LTPA/week). In addition, some researchers
selected an arbitrary LSI cut-point (e.g., LSI ≥ 15; [43],
LSI ≥ 16; [44], or LSI ≥ 27; [45, 46]; a frequency cut-
point (≥5 bouts of moderate-to-strenuous LTPA/week;
[47]), or a MET × hours/week cut-point (≥10 MET ×
hours/week; [48]) to classify cancer survivors as active
and insufficiently active.
GSLTPAQ validity evidence in cancer survivors
There was no study specifically designed to estimate the
validity of the GSLTPAQ LSI or classification scoring
system in cancer survivors. However, two studies re-
ported a Pearson correlation coefficient between the LSI
and accelerometer counts [49, 50] and another reported
such correlation between the LSI and pedometer step
counts [51]. These correlations are: .53 [.23; .95] (N = 33,
breast cancer survivors [49]); .57 [.26; 1.00] (N = 28,
leukemia survivors [50]); and .31 [.04; .60] (N = 51,
breast cancer survivors [51]). Thus, there is one uncer-
tain level 3 and two uncertain level 1 pieces of validity
evidence based on the relationship between GSLTPAQ
and device-based PA scores in cancer research.
Identified in this review, there were six RCTs (reported
in seven articles) evaluating structured and prescribed
exercise interventions of 4 to 12 weeks in duration on
PA behavior [51-57]. The interventions included a mix
of aerobic (using cycle ergometer, treadmill or rowing
ergometer) and resistance strength training (using body
weight, free weight or muscular fitness machine). The
intensity prescribed varied from 55 % (mild intensity) to
85 % (moderate to vigorous intensity) of participants’
maximal heart rates, depending on their initial levels of
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physical fitness. The methodological quality and findings
of the studies are summarised in Table 3. In five of the
six studies, cancer survivors were prescribed at least two
sessions of MVPA per week, and were also counselled to
perform up to three additional home-based PA sessions.
The computed effect size for change in LSI for the
exercise group in all those five studies was large. In con-
trast, the computed effect size for change in LSI for the
control group was trivial/small in four studies [51, 52,
54, 55]. In one small study, a large change in LSI was
also computed for the cancer survivors of the control
group [53]. For one study [57], prostate cancer survivors
Fig. 1 Flow Diagram. Adapted from: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group [33]. Fig. 1 depicts the number of studies
screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.
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were only prescribed two sessions of resistance training
(moderate intensity) per week for 12 weeks. Although
the participants were encouraged to supplement their
resistance exercise training with home-based aerobic
sessions, there was no formal behavioral home-based
intervention offered. The computed effect size for
change in LSI was small-to-medium for the intervention
group and trivial for the control group. Sample sizes
were < 100 for five studies and 100 for another one.
Therefore, five satisfactory (four that were deemed un-
certain [+ ?]) and one unsatisfactory (deemed uncertain
[− ?]) effect sizes assessing the relative change in LSI
were computed among the RCTs.
Discussion
This study documented the frequency of use of the
GSLTPAQ for ranking and classification purposes, sum-
marized the use of the GSLTPAQ based on item content
and scoring methods, and evaluated the validity evidence
supporting the use of the GSLTPAQ among cancer sur-
vivors. The aims of this study were achieved based on a
systematic review of 212 English-written published arti-
cles that reported using the GSLTPAQ among cancer
survivors between 1997 and 2014.
The questionnaire was frequently used for classifying
cancer survivors into active and insufficiently active cat-
egories in spite of the fact that there was no standard clas-
sification system for the GSLTPAQ available before 2011
[12]. None of the retrieved articles used the scoring system
suggested by Godin [12] for interpreting the GSLTPAQ
LSI score. In most cases, investigators modified the content
of the questionnaire and used number of minutes, used an
arbitrary or a distribution-based (e.g., quartile of LSI) cut-
point to create their own classification system. Arbitrary or
distribution-based classification can be potentially
misleading [58, 59]. For example, such classification might
have resulted in creating groups of insufficiently active and
active individuals even if most of the sample was active.
Similarly, the term ‘sedentary’ might not be appropriate for
describing cancer survivors reporting 0 min of moderate-
to-strenuous LTPA [60]. Some cancer survivors classified
as sedentary might have engaged in mild PA, whereas
some of them classified as active might have been seden-
tary for a large proportion of their waking time (i.e., being
an ‘active couch potato’ [61]). Therefore, without rationale
for classification, both arbitrary and distribution-based
classifications are liable to cut-point bias and prone to mis-
leading interpretation [26, 62]. Based on the findings of the
current review, researchers are encouraged to use the LSI
for ranking purpose and the GSLTPAQ classification cod-
ing system [12] for classification purpose. One study con-
ducted among healthy adults [63] and breast cancer
survivors [64] now provide support for the use of the
GSLTPAQ classification coding system at the group level.
Over 80 % of the published articles using the GSLTPAQ
among cancer survivors did not use the original version of
this questionnaire. This finding may not be surprising
given Sternfeld and Goldman-Rosas’s [36] observations
about researchers and practitioners making ‘small’
modifications to existing PA questionnaires. The most
frequent modification was the collection of informa-
tion on the average duration (in minutes) for mild,
moderate, and strenuous LTPA (e.g., [65–69]). Despite
this common alteration to the GSLTPAQ, none of the
retrieved studies provided validity evidence supporting the
use and interpretation of scores derived from the modified
GSLTPAQ. Without such evidence it is unknown if this
modification has a trivial or large impact on the validity of
the questionnaire. One study published in 2015 reported
‘fair’ ranking (rank-order correlation coefficient = 0.51),
Fig. 2 Number of Articles Reporting Using the Godin-Shephard Leisure-Time Physical activity Questionnaire in Cancer-Related Research (1997–2014)
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but ‘poor’ agreement (intraclass correlation coefficient =
0.31) between reported minutes of MVPA assessed with a
modified version of the GSLTPAQ and an accelerometer
among prostate cancer survivors [70]. However, this modi-
fication lengthens the questionnaire and may add recall
and calculation burden to respondents [14, 26, 29]. More-
over, as the number of modifications increases (i.e., asking
about the average duration of LTPA, changing the recall
period, or creating and interpreting a new scoring system)
the integrity of the information may be questioned. Flexi-
bility in methods used to assess and interpret the score ob-
tained from the GSLTPAQ is a source of heterogeneity
that may contribute to inconsistent results across studies.
Standardization in the use and interpretation of the
GSLTPAQ in oncology research is warranted.
No study was found with the primary objective to esti-
mate the validity of the GSLTPAQ in cancer survivors.
Nonetheless, three studies reported validity evidence based
on the relationship between the LSI and accelerometer or
step counts [49–51]. The identified correlation coefficients
compare favorably to those obtained from previous sys-
tematic reviews [37, 71–73] and previous studies reporting
on the association between LSI and accelerometer data [5,
23] conducted outside the oncology context. Taken to-
gether, a limited amount of validity evidence from oncol-
ogy research tends to support the use of the GSLTPAQ
and the interpretation of the LSI for ranking purpose
among cancer survivors.
Overall, findings support the use of the GSLTPAQ and
the interpretation of the LSI for assessing relative change
in PA among cancer survivors. This is a key addition to
the literature because validity evidence supporting the use
of the GSLTPAQ for assessing changes in LTPA among
cancer survivors is scarce [16, 37]. However, the scope of
these findings is limited by the fact that effect sizes were
mostly derived from the synthesis of small samples of can-
cer survivors (N ≤ 100). As a result, the computed effect
sizes lacked precision, which reflect uncertainty [37, 39].
Furthermore, because validation was not the primary aim
of any oncology studies reviewed, the summarized findings
may be hampered by within-study selective reporting bias
[74]. Hence, it is likely that significant validity estimates
were more likely to be reported than non-significant ones.
Given that there is initial evidence suggesting that the sen-
sitivity to changes of the LSI might vary with the levels of
PA habits [25], it is recommended to use the GSLTPAQ to
assess changes in LTPA only among cancer survivors hav-
ing weak PA habits (i.e., inactive adult cancer survivors;
[75]). Nonetheless, the lack of evidence regarding the abil-
ity of the questionnaire to accurately assess changes in
LTPA limits our confidence in studies assessing change in
LTPA across the cancer trajectory (i.e., before diagnosis,
during treatment, after treatment). Additional studies gath-
ering sensitivity to change validity evidence among cancer
survivors are warranted.
The practical recommendations and future avenues of
research concerning the use of the GSLTPAQ among can-
cer survivors are summarized in Table 4. They are based
on the available validity evidence, both within [49–57, 64]
and outside [5, 11, 22–25, 63] of oncology research. Add-
itional validation studies, conducted among sufficiently
large sample (N ≥ 100) of cancer survivors are needed, es-
pecially in children, adolescents, and survivors of other
types of cancer than breast cancer. Although one study
suggests that social desirability has limited impact on LSI
among college students [24], it is impossible to ascertain
Table 1 Characteristics of the articles included in the systematic
review (k = 212)
Characteristics Median [IQR] Range
(min - max)
Year of publication (year) 2010
[2007–2013]
1997 - 2014
Sample size (N)a 129 [56–359] 1 - 9105
Sample mean age (year)a 58 [52–64] 11 - 77
Sample mean percentage of
female (%)
















Hematological (leukemia, myeloma) 10 4.7
Hodgkin/non-Hodgkin lymphoma 8 3.8
Endometrial 7 3.3
Brain/glioma 7 3.3




Survivors from different types of cancer 54 25.5
The unit of observation is the published article. IQR: 25th-75th interquartile range.
k: number of published articles included in the systematic review. ak = 211 due to
missing information in one article; for all the other variables, k = 212. bOne study
included participants from Canada and USA (k = 1; 0.5 %) and one study included
participants from Australia and New Zealand (k = 1; 0.5 %). cOther countries
included New Zealand (k = 4; 1.9 %), Ireland (k = 3; 1.4 %), Norway (k = 3; 1.4 %),
Taiwan (k = 3; 1.4 %), Spain (k = 2; 0.9 %) and Italy (k = 1; 0.5 %).
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that this finding generalized to cancer survivors. Similarly,
it would be relevant to assess whether or not examples of
LTPA provided for each intensity category of the question-
naire are pertinent and understood by cancer survivors.
Although the recall time frame of the original GSLTPAQ
is a ‘typical 7-day period’, it may also be appropriate to use
the ‘past 7-day (i.e., the last week)’ recall timeframe depend-
ing on the measurement purpose and study design [36].
The ‘past 7-day (i.e., the last week)’ recall timeframe may be
used provided that it is reasonably representative of the typ-
ical LTPA in cancer survivors. Moreover, the ‘past 7-day
(i.e., the last week)’ recall timeframe is not appropriate in
case–control study as the timeframe of the exposure (i.e.,
LTPA) does not precede the health outcome. Additional
studies testing whether or not the recall period influences
the quality of the GSLTPAQ for different specific purpose
and study design are needed.
Lastly, the GSLTPAQ’s characteristic most likely asso-
ciated with measurement error is misreporting the in-
tensity of the activities (e.g., reporting a mild LTPA as
moderate LTPA or reporting a moderate LTPA as
strenuous LTPA), which likely occurs when the per-
ceived and absolute intensity of a given LTPA are differ-
ent [26, 29]. In this regard, asking about mild LTPA
may reduce the misreporting of LTPA intensities [76].
Therefore, it is advisable to ask about mild LTPA, even
if the investigators are only interested in moderate and
strenuous LTPA.
Limitations
This study has some limitations. Despite the fact that a
thorough method was implemented to identify and select
articles, only one reviewer screened citations for eligibility.
In addition, there were inadequate details in articles re-
garding the recall period of the GSLTPAQ for 23.6 % of
the reviewed studies. Although authors cited the original
publication of the GSLTPAQ and appeared to have used
the original version of this questionnaire, we could not as-
certain that the recall period was either the ‘typical week’
or ‘last week’. No attempt was made to contact the authors
of those articles to obtain clarifications on the recall period
used. Lastly, our search strategy was restricted to English-
language articles published in peer-review journals. We ac-
knowledge that this may have resulted in an oversampling
of small and moderate sample size studies reporting signifi-
cant and large effect sizes. Although publication bias is
suspected, especially for the findings related to the validity
estimates of the GSLTPAQ, how much of an impact it
Table 3 Sensitivity to change validity estimate for the godin-shephard leisure-time physical activity in oncology research





















Bourke et al. [52]a Low (50) Low Yes (95 %) Low Low 2.31 .24
Bourke et al. [53]a Low (18) Highb Yes (90 %) Unclearc Highd 1.67 1.17
Bourke et al. [54]a Low (100) Low Yes (88 %) Low Low 1.63 .30
Broderick et al. [55] Low (43) Low Yes (78 %) Unclearc Highd 1.35 -.14
Cormie et al. [57]a Low (20) Low Yes (93 %) Low Low .45 .10
Perna et al. [51] Low (51) Low Yes (83 %) Low Low 1.88 .27
LSI Leisure score index. Validity estimates are reported as Cohen’s d. aThe recall period of the GSLTPAQ was not explicitly stated. bOnly data analysts were blind to group
assignment.cReported only for socio-demographic and medical variables; however, the analyses were adjusted for baseline LSI. dLast observation carried forward was
the strategies used to deal with missing data. dComplete cases analysis was performed; two participants dropped-out (7 %)
Table 2 Use of the godin-shephard leisure-time physical activity in oncology research
Item content (n = 206)a Recall period (n = 162)c Measurement units (n = 210)e
Frequency Frequency and duration Typical or last week Other recall periods Frequency or LSI Other units
General purpose
Ranking only 45 (21.8 %) 53 (25.7 %) 41 (25.3 %) 32 (19.8 %) 50 (23.8 %) 49 (23.3 %)
Classifying only 6 (2.9 %) 51 (24.8 %) 9 (5.6 %) 37 (22.8 %) 3 (1.4 %) 57 (27.1 %)
Ranking and classifying 6 (2.9 %) 45 (21.8 %) 7 (4.3 %) 36 (22.2 %) 8 (3.8 %) 43 (20.5 %)
Total 57 (27.7 %)b 149 (72.3 %) 57 (35.2 %) 105 (64.8 %)d 61 (29.1 %) 149 (71.0 %)
The unit of observation is the published article. aWhether or not duration items were measured was undetermined for four studies owing to the lack of
information reported in the reviewed articles. bFor the two studies for which the measurement purpose was undetermined, duration items were not assessed.
cThe recall period of the questionnaire was undetermined for 50 studies owing to the lack of information reported in the reviewed articles. dFor the two studies
for which the measurement purpose was undetermined, the recall period was ‘other’ for one study. eThe general measurement purpose was undetectable for two
studies owing to the lack of information reported in the reviewed articles.
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might have had on review findings is unknown. It is worth
noting that most of the samples in the articles reviewed in-
cluded primarily North American female adult breast can-
cer survivors. Overall, participants were highly educated
and volunteered to participate in a study. Thus, the results
of this review may not be generalizable to other cancer
survivor populations.
Conclusion
This systematic review showed that the use of the
GSLTPAQ for classification purpose in oncology research is
common. Standardization in the use and interpretation of
the GSLTPAQ in oncology research is warranted. Although
limited, the current state of evidence tends to support the
use of the original form of the GSLTPAQ and interpreting
the LSI for ranking respondents from the lowest to highest
levels of LTPA within a given sample of cancer survivors.
Thus, the GSLTPAQ’s LSI may be used in cancer survivors’
studies for (i) identifying the correlates/determinants of
LTPA behavior, (ii) verifying whether or not LTPA is a risk
or a protective factor of relevant health-related outcomes,
and (iii) evaluate the efficacy of LTPA behavior change
interventions.
Additional files
Additional file 1: Components of the Comprehensive Systematic
Review Concerning the use of the Godin-Shephard Leisure-Time
Physical Activity Questionnaire in Oncology Research. Description of
data: Reports full details of the information source and search strategy,
study selection, data collection, and extraction processes.
Table 4 Practical recommendations and avenues of research for the validation of the GSLTPAQ in oncology research
Most popular specific uses Practical recommendations Avenues of research- types of validity evidence neededa
Use as a risk or protective factor for predicting
health-related outcomes.
Supported Relation with other PA measures in cancer survivors
Property of the measure required: Produce valid ranking.
Use as a measure of past behavior for
predicting LTPA behavior, barriers or motivation.
Supported Relation with other PA measures in cancer survivors
Supported Relation with other PA measures in cancer survivors
Property of the measure required: Produce valid
ranking.
Use as a behavioral outcome in studies aiming
at identifying the determinants of LTPA behavior.
Property of the measure required: Produce valid
ranking.
Use as behavioral outcome in studies evaluating
the effectiveness of behavior change intervention
to increase LTPA.
Supported Behavioral stability among initially inactive cancer
survivors;
Relation with other PA measures in cancer survivors;
Sensitivity to changes in LTPA among initially inactive
cancer survivors.Property of the measure required: Produce valid
ranking; detect and quantify relative change in
LTPA behavior.
Use as behavioral outcome in studies evaluating
the effectiveness of behavior change intervention
to maintain LTPA.
Not supported Behavioral stability among initially active cancer
survivors;
Relation with other PA measures among initially active
cancer survivors; Sensitivity to changes in LTPA among
initially active cancer survivors.Property of the measure required: Produce valid
ranking; detect and quantify relative change in
LTPA behavior.
Use as behavioral outcome for comparing
baseline levels of LTPA of cancer survivors
randomly allocated to one of the experimental
conditions.
Supported Relation with other PA measures in cancer survivors.
Property of the measure required: Produce valid ranking.
Use as a behavioral outcome for evaluating LTPA behavior
change across the cancer experience (i.e., before diagnosis,
during treatment, and after treatment).
Not supported Behavioral stability in cancer survivors; Relation with
other
PA measures in cancer survivors; Sensitivity to changes
LTPA in cancer survivors.
Property of the measure required: Produce
valid ranking; detect and quantify relative change in
LTPA behavior.
Use as a behavioral outcome for reporting and describing
PA prevalence. Property of the measure required: Produce
stable estimates of LTPA at the population level that are
free of bias (i.e., accurately estimate LTPA levels)
Not supported Behavioral stability in cancer survivors; Relation with
other PA measures in cancer survivors (absolute
interpretation).
aBased on the approach suggested by Masse and de Niet [16]. LTPA leisure-time physical activity, PA physical activity.
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Additional file 2: Characteristics of the Sample for Cancer Survivors
Published Article that Used the Godin-Shephard Leisure-Time Physical
Activity. Description of data: Reports a detailed summary of the characteristics
of each study included in the review.
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activity.
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